Baseline Parameters | Expression of serum BPGM | P value | |
---|---|---|---|
Negative n = 50 | Positive n = 35 | ||
Gender | |||
 Male | 33 (66.0) | 22 (62.9) | 0.765 |
 Female | 17 (34.0) | 13 (37.1) |  |
Age, years | 68 (20) | 64 (24) | 0.951 |
APACHE II, score | 23 (9) | 27 (12) | 0.022 |
SOFA, score | 7 (2) | 7 (2) | 0.924 |
Comorbidities | |||
 Diabetes Mellitus | 16 (32.0) | 11 (31.4) | 0.956 |
 Immunosuppression | 0 (0.0) | 1 (2.9) | 0.412 |
 IHD | 0 (0.0) | 2 (1.2) | 0.167 |
 Hypertension | 25 (50.0) | 14 (40.0) | 0.363 |
 COPD | 2 (4.0) | 2 (5.7) | 0.713 |
 CKD | 4 (8.0%) | 4 (11.4) | 0.824 |
Lactate, mmol/l | 3.2 (2.0) | 3.4 (3.5) | 0.165 |
PCT, ng/ml | 27.6(59.7) | 28(89.0) | 0.422 |
LDH, IU/l | 341 (472) | 358 (466) | 0.432 |
AG, mmol/l | 18 (8) | 17.8 (10) | 0.782 |
CK, IU/l | 203 (338.5) | 134 (862) | 0.486 |
CK-MB, ng/ml | 25 (28) | 26 (33) | 0.652 |
NT-proBNP, pg/ml | 3440 (4156) | 4834 (5419) | 0.114 |
cTnI, ng/ml | 0.04 (0.30) | 0.18 (0.98) | 0.033 |
LVEF-S,% | 50 (6.0) | 45 (13) | 0.001 |
Tei Index | 0.39 (0.17) | 0.62 (0.24) | 0.001 |